Re Phos Tablet
Calcium Acetate
667mg
Deurali Janta Pharmaceuticals Pvt. Ltd.
| Pack size | 1 |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 7.00 NPR |
Indications
Re Phos Tablet is used for:
Hyperphosphatemia
Adult Dose
Child Dose
Renal Dose
Administration
Should be taken with food.
Contra Indications
Patients with hypercalcaemia.
Precautions
Patients undergoing chronic hemodialysis. Renal impairment, diseases associated with hypercalcaemia such as sarcoidosis & some malignancies. Avoid in patients with calcium renal calculi or a history of renal calculi.
Maintenance of normal serum calcium levels is important for maternal and fetal well being; hypercalcemia during pregnancy may increase risk for maternal and neonatal complications(eg, stillbirth, preterm delivery, neonatal hypocalcemia and hypoparathyroidism);calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment
Lactation: unknown
Pregnancy-Lactation
Interactions
Tetracycline antibiotics, thiazide diuretics, vit D, corticosteroids, bisphosphonates, fluoride, some fluoroquinolones.
Adverse Effects
Side effects of Calcium Acetate :
Arrhythmias,Hypomagnesemia,Hypophosphatemia,Hypotension,Nausea,Pruritus (rare),Weakness
Hypercalcemia,Anorexia,Coma,Confusion,Delirium,Headache,Nausea,Vomiting
Mechanism of Action
Sequesters phosphate in the intestine by forming insoluble phosphates that are excreted faecally, thus reducing serum phosphate conc & secondary hyperparathyroidism.
Note
Re Phos 667mg Tablet manufactured by Deurali Janta Pharmaceuticals Pvt. Ltd.. Its generic name is Calcium Acetate. Re Phos is availble in Nepal.
Farmaco Nepal drug index information on Re Phos Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.